Cambridge, MA, United States of America

Holger Patzke

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Holger Patzke: Innovator in Gene Therapy

Introduction

Holger Patzke is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of gene therapy. With a total of six patents to his name, he has made remarkable strides in developing innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, one notable invention is focused on "Compositions and methods for delivery of AAV." This invention provides compositions and methods for the preparation, manufacture, formulation, and therapeutic use of adeno-associated virus (AAV) particles aimed at preventing and/or treating diseases. Another significant patent is titled "Frataxin expression constructs having engineered promoters and methods of use thereof." This disclosure relates to compositions and methods for enhancing the expression of frataxin (FXN), which is crucial for treating conditions such as Friedreich's ataxia and other neuromuscular or neurological disorders.

Career Highlights

Holger Patzke is currently associated with Voyager Therapeutics, Inc., where he continues to push the boundaries of gene therapy research. His work has been instrumental in advancing therapeutic strategies that leverage AAV technology for effective disease management.

Collaborations

Throughout his career, Holger has collaborated with esteemed colleagues, including Dinah Wen-Yee Sah and Qingmin Chen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Holger Patzke's contributions to gene therapy through his patents and collaborative efforts highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches that can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…